Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
Status:
Completed
Trial end date:
2018-07-27
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy, safety and tolerability of perfluorohexyloctane
(NOV03) at two different dosing regimens compared to saline solution in subjects with Dry Eye
Disease (DED).